Ir.minervaneurosciences.com

  1. Home
  2. Ir.minervaneurosciences.com

Minerva Neurosciences Submits New Drug Application to FDA for

WebWALTHAM, Mass., Aug. 22, 2022 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company …

Actived: 5 days ago

URL: https://ir.minervaneurosciences.com/news-releases/news-release-details/minerva-neurosciences-submits-new-drug-application-fda

Minerva Neurosciences Announces Study Results Demonstrating

WebCompany to Request Pre-NDA Meeting with U.S. Food and Drug Administration. WALTHAM, Mass., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Minerva …

Category:  Food Go Health

Roluperidone Update

WebNumber of patients reporting schizophrenia symptoms worsening and the median time (in days) to recovery/resolution. During the double-blind phase of the …

Category:  Health Go Health

Press Releases Minerva Neurosciences, Inc.

WebJune 28, 2023. Minerva Neurosciences Announces $20 Million in Private Placement Priced at a Premium to Market. BURLINGTON, Mass., June 28, 2023 (GLOBE NEWSWIRE) -- …

Category:  Health Go Health

Catalent and Minerva Neurosciences Enter Commercial Supply …

WebWALTHAM, Mass. and SOMERSET, N.Y., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage …

Category:  Health Go Health

Minerva Neurosciences to Host R&D Day Focused on Unmet …

WebWALTHAM, Mass., Feb. 21, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq:NERV), a clinical-stage biopharmaceutical company focused on the …

Category:  Health Go Health

INVESTORS & MEDIA

WebBURLINGTON, Mass., Dec. 28, 2022 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the …

Category:  Health Go Health

INVESTORS & MEDIA

WebFDA confirms acceptance of the filing of the NDA for roluperidone. Application has been granted a standard review. FDA has assigned a Prescription Drug …

Category:  Health Go Health

Minerva Neurosciences Announces $20 Million in Private …

WebBURLINGTON, Mass., June 28, 2023 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the …

Category:  Health Go Health

Minerva Neurosciences Announces the NDA Filing for …

WebFDA grants appeal and files NDA. BURLINGTON, Mass., May 01, 2023 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage …

Category:  Health Go Health

Minerva Neurosciences Names Dr. Jay Saoud as Senior Vice …

WebWALTHAM, Mass., Sept. 11, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the …

Category:  Health Go Health

Minerva Neurosciences to Present at Cowen and Company 37th …

WebMinerva Neurosciences to Present at Cowen and Company 37th Annual Health Care Conference on March 7, 2017

Category:  Health Go Health

INVESTORS & MEDIA

WebBURLINGTON, Mass., Oct. 17, 2022 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the …

Category:  Health Go Health

Minerva Neurosciences Receives Complete Response Letter from …

WebBURLINGTON, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the …

Category:  Health Go Health

Minerva Neurosciences to Host Key Opinion Leader Meeting on …

WebBreakfast meeting to be held on Friday, March 6, 2020 in New York. WALTHAM, Mass., Feb. 28, 2020 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. …

Category:  Health Go Health

Minerva Neurosciences Names Richard Russell President

WebWALTHAM, Mass., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the …

Category:  Health Go Health

Corporate Presentation

WebMinerva Neurosciences (NASDAQ: NERV) Founded in 2014. Our goal is to transform the lives of patients suffering from CNS disease including schizophrenia, depression, …

Category:  Health Go Health

Minerva Neurosciences to Present at Baird 2014 Health Care …

WebCAMBRIDGE, Mass., Aug. 28, 2014 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq:NERV), a leader in the development of new therapies to treat neuropsychiatric …

Category:  Health Go Health

Events & Presentations Minerva Neurosciences, Inc.

WebMinerva Neurosciences First Quarter 2023 Conference Call. Listen to webcast. Mar 8, 2023 at 8:30 AM EST. Mar 8, 2023. 8:30 AM EST.

Category:  Health Go Health

Top Categories

 › Appendicitis

 › Headaches

 › Gout

 › Women's Health

 › Thyroid

 › Sleep

 › Skin

 › Sexual Health

 › Senior Health

 › Pregnancy

 › Oral Health

 › Neurology

 › Migraine

 › Mental Health

 › Men's Health

 › Menopause

 › Medications

 › Lung Conditions

 › Infectious Disease

 › HIV/AIDS

Popular Searched

 › Dublin mental health dublin ga

 › Occupational health and safety philippines

 › Ellicott city health rehab center

 › Free adult health flashcards

 › Amerihealth vip care plus form

 › Momentum health incentive program

 › Salts health care products

 › Green impact for health 2023

 › Scituate ma board of health

 › Center well home health number

Recently Searched

 › Prohealth mount kisco ny

 › Ministry home health care wisconsin

 › What is health promoting behavior

 › Prudential health insurance claim form

 › Continue care baptist health paducah

 › Singapore health care plan

 › Wilmington health associates patient portal

 › Washington state health care board meeting

 › Wake forest baptist health kronos

 › Washington state health care authority meeting